SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258

Detalles Bibliográficos
Autores principales: Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de rhumatologie. Published by Elsevier Masson SAS. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480129/
https://www.ncbi.nlm.nih.gov/pubmed/34600149
http://dx.doi.org/10.1016/j.jbspin.2021.105281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480129/
https://www.ncbi.nlm.nih.gov/pubmed/34600149
http://dx.doi.org/10.1016/j.jbspin.2021.105281

Ejemplares similares